legal-news
1:24-cv-00391 Arcutis Biotherapeutics, Inc. v. Padagis Israel Pharmaceuticals Ltd. et al
24-cv-00391
|
|
Filed
Active
Sign in to follow this case
Advertisement
description
Case Summary
In the case 1:24-cv-00391 Arcutis Biotherapeutics, Inc. v. Padagis Israel Pharmaceuticals Ltd. et al, Arcutis Biotherapeutics, a pharmaceutical company, has initiated litigation against Padagis Israel Pharmaceuticals and other defendants. The dispute likely involves issues related to pharmaceutical products, such as patent rights, regulatory compliance, or contractual disagreements, although specific details are not provided in the available letter filing. The case is currently pending, with procedural developments documented through court filings.
Key Issues
- • Pharmaceutical patent or intellectual property rights
- • Regulatory compliance in drug manufacturing or distribution
- • Contractual obligations between pharmaceutical entities
- • Jurisdictional considerations in international pharmaceutical disputes
- • Procedural matters in civil litigation
Advertisement
Case Timeline
1 event
info
Other
April 14, 2026
1:24-cv-00391 Arcutis Biotherapeutics, Inc. v. Padagis Israel Pharmaceuticals Ltd. et al
[Letter] (<a href="https://ecf.ded.uscourts.gov/doc1/04317176554?caseid=85362&de_seq_num=358">100</a>)
Advertisement
newspaper
1 article